Verastem, Inc.
Status: Publicly traded
Direct answer
Verastem, Inc. is publicly traded on NASDAQ under the ticker VSTM.
Verastem, Inc. is an emerging biopharmaceutical company dedicated to the creation and commercialization of innovative therapeutic agents for cancer treatment. A primary asset in its pipeline is VS-6766, a novel dual RAF/MEK inhibitor that operates by a "clamp" mechanism. This unique action effectively blocks the kinase activity of MEK and disrupts RAF's ability to phosphorylate MEK. The company is actively advancing...
Can you invest in Verastem, Inc.?
Yes. Verastem, Inc. trades publicly on NASDAQ as VSTM.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Verastem, Inc.
Detailed equity research is provided by MarketSnap.